Pharmacogenetic studies of drug response in schizophrenia

Eva J Brandl, James L Kennedy, Daniel J Müller, Pharmacogenetics of Antipsychotics The Canadian Journal of Psychiatry. ,vol. 59, pp. 76- 88 ,(2014) , 10.1177/070674371405900203

Majid Kheirollahi, Elahe Kazemi, Saeideh Ashouri, Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case–Control Studies Cellular and Molecular Neurobiology. ,vol. 36, pp. 1- 10 ,(2016) , 10.1007/S10571-015-0229-Z

E J Brandl, A K Tiwari, C C Zai, E L Nurmi, N I Chowdhury, T Arenovich, M Sanches, V F Goncalves, J J Shen, J A Lieberman, H Y Meltzer, J L Kennedy, D J Müller, Genome-wide association study on antipsychotic-induced weight gain in the CATIE sample. Pharmacogenomics Journal. ,vol. 16, pp. 352- 356 ,(2016) , 10.1038/TPJ.2015.59

Siow-Ann Chong, Ene-Choo Tan, Chay Hoon Tan, Mythily, Yiong Huak Chan, Polymorphisms of dopamine receptors and tardive dyskinesia among Chinese patients with schizophrenia American Journal of Medical Genetics. ,vol. 116, pp. 51- 54 ,(2003) , 10.1002/AJMG.B.10004

Y C Chagnon, C Mérette, R H Bouchard, C Émond, M-A Roy, M Maziade, A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses Molecular Psychiatry. ,vol. 9, pp. 1067- 1074 ,(2004) , 10.1038/SJ.MP.4001537

Younger W.-Y. Yu, Shih-Jen Tsai, Ching-Hua Lin, Chiu-Peng Hsu, Kuan-Hung Yang, Chen-Jee Hong, Serotonin-6 receptor variant (C267T) and clinical response to clozapine. Neuroreport. ,vol. 10, pp. 1231- 1233 ,(1999) , 10.1097/00001756-199904260-00014

Nora Hamdani, Mickaël Bonnière, Jean Adès, Michel Hamon, Claudette Boni, Philip Gorwood, Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics Neuroscience Letters. ,vol. 377, pp. 69- 74 ,(2005) , 10.1016/J.NEULET.2004.11.070

C. Anthony Altar, John Hornberger, Ashwini Shewade, Victor Cruz, Jill Garrison, David Mrazek, Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy International Review of Psychiatry. ,vol. 25, pp. 509- 533 ,(2013) , 10.3109/09540261.2013.825579

AFY Al Hadithy, SA Ivanova, P Pechlivanoglou, A Semke, Olga Fedorenko, E Kornetova, L Ryadovaya, JRBJ Brouwers, Bob Wilffert, Richard Bruggeman, AJM Loonen, None, Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 33, pp. 475- 481 ,(2009) , 10.1016/J.PNPBP.2009.01.010

Eveline Jaquenoud Sirot, Gianni Cucchia, Mich??le Jonzier-Perey, Pierre Baumann, Delphine Allorge, Franck Broly, Chin B. Eap, Stefan Bender, Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene. Journal of Clinical Psychopharmacology. ,vol. 24, pp. 214- 219 ,(2004) , 10.1097/01.JCP.0000116646.91923.2F